Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-14 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-12 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-10 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-08 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |